Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03594266 · ClinicalTrials.gov registry record · NA

Comparison of the Effects of Two Spinal Cord Stimulation (SCS) Therapies on Subject Reported Pain (BENEFIT-02)

A NA study, sponsored by Biotronik.

Completed
Registry status
NA
Development phase
136
Enrollment target

NCT03594266 is a NA study that has completed, run by Biotronik. The registered enrollment target is 136 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03594266, a NA study, has completed, sponsored by Biotronik.

COMPLETED
Registry status
NA
Development phase
136 participants
Enrollment target

Study Summary

A BIOTRONIK wearable stimulator will be utilized in order to investigate the effects of two study spinal cord stimulation (SCS) therapies on subject reported pain and paresthesia perception observed over 12 days of study stimulation testing following the conclusion of a successful SCS commercial trial.

Interventions

  • DEVICE Therapy A spinal cord stimulation parameter set using BIO-RNA system and associated components
  • DEVICE Therapy B spinal cord stimulation parameter set using BIO-RNA system and associated components

Trial Details

FieldValue
Enrollment Target 136 participants
Start Date 2018-08-01
Est. Completion 2020-03-27
Phase NA

Sponsor

Biotronik

30 total trials

What the Registry Record Tells You About NCT03594266

The ClinicalTrials.gov registry entry for NCT03594266 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biotronik, which has 30 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Therapy A spinal cord stimulation parameter set using BIO-RNA system and associated components is the first listed.

NCT03594266 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03594266 about?

NCT03594266 is a clinical study titled "Comparison of the Effects of Two Spinal Cord Stimulation (SCS) Therapies on Subject Reported Pain (BENEFIT-02)". A BIOTRONIK wearable stimulator will be utilized in order to investigate the effects of two study spinal cord stimulation (SCS) therapies on subject reported pain and paresthesia perception observed over 12 days of study stimulation testing following the conclusion of a successful SCS commercial tri...

What is the current status of trial NCT03594266?

This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2018-08-01. Estimated completion is 2020-03-27.

What interventions are being tested in trial NCT03594266?

The interventions under investigation include: Therapy A spinal cord stimulation parameter set using BIO-RNA system and associated components (DEVICE), Therapy B spinal cord stimulation parameter set using BIO-RNA system and associated components (DEVICE).

Who is sponsoring clinical trial NCT03594266?

This trial is sponsored by Biotronik, which has 30 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.